ヒト脳梗塞巣におけるInterleukin‐6発現の意義について

書誌事項

タイトル別名
  • Role of endothelin-1 and interleukin-6 immunoreactivity in infarcted area of human stroke.

この論文をさがす

抄録

Recent descriptions of the identification of the vasoconstrictor peptide, endothelin-1 (ET-1), and inflammatory interleukin-6 (IL-6) have attracted much attention and excited speculation regarding their possible pathological significance in cerebral infarction. The present study focused on the expression of ET-1 and IL-6 in the human stroke brain in relation to the healing process of occlusive cerebrovascular disease. Eight patients with occlusive cerebrovascular disease were employed. For immunohistochemical studies on ET-1 and IL-6, polyclonal anti-human ET-1 antibody (Peptide Institute Inc., Japan) and polyclonal rabit antibody against human IL-6 (Genzyme, Boston) were used, respectively. In the stroke brain at the chronic phase of cerebrovascular accident, the immunohistochemical method demonstrated simultaneous production of both ET-1 and IL-6 associated with astrocyte proliferation in serial sections derived from the boundary area. In addition, the endothelial cells demonstrated strong staining for ET-1 as well as for IL-6. The percentages of ET-1 expression in the astrocytes and endothelium were 87.6 ± 12.8% and 93.2 ± 7.8%, respectively. IL-6 also exhibited simultaneous expression in both the astrocytes (92.9 ± 5.4%) and endothelium (90.0 ± 9.9%). ET-1 and IL-6 can thus be produced by both astrocytes and endothelium, and act on them in intercellular reactions. The presence of IL-6 immunoreactivity in the infarcted area is functionally linked with ET-1. Our data indicate that, although the precise order remains unknown, a sequence of immunologic events may play a role in the pathophysiology of human stroke.

収録刊行物

  • 脳卒中

    脳卒中 19 (2), 103-109, 1997

    一般社団法人 日本脳卒中学会

参考文献 (19)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ